首页> 美国卫生研究院文献>Annual Meeting of the American Climatological Association >A Novel Approach to Restore Lung Immunity During Systemic Immunosuppression
【2h】

A Novel Approach to Restore Lung Immunity During Systemic Immunosuppression

机译:一种在系统性免疫抑制过程中恢复肺部免疫力的新方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Systemic immunosuppression accounts for significant morbidity and mortality worldwide. Pulmonary infections represent the most common cause of death in these patients. The resident inflammatory cell in the lung is the alveolar macrophage (AM) and its function is markedly diminished by immunosuppression. We hypothesized that AMs from normal mice with or without gene transfer of the gamma interferon gene inside the macrophages, can restore alveolar immunity in immunosuppressed mice with severe combined immunodeficiency syndrome (SCID). To test this hypothesis we intratracheally instilled normal and IFN-γ activated macrophages to the lungs of SCID mice. We demonstrated that airway delivery of macrophages results in widespread alveolar distribution, improved phagocytic function and ability to clear opportunistic infections such as Pneumocystis carinii. Airway delivery of IFN-γ expressing macrophages further increased the function of alveolar macrophages. Reconstitution of the lungs of immunosuppressed mice with normal or activated AMs can restore alveolar immunity despite ongoing systemic immunosuppression.
机译:系统性免疫抑制在全世界范围内占很大的发病率和死亡率。在这些患者中,肺部感染是最常见的死亡原因。肺中驻留的炎性细胞是肺泡巨噬细胞(AM),其免疫抑制作用使其功能显着减弱。我们假设来自正常小鼠的AMs在巨噬细胞内部具有或不具有γ干扰素基因的基因转移,都可以在患有严重合并免疫缺陷综合症(SCID)的免疫抑制小鼠中恢复肺泡免疫。为了验证这一假设,我们向SCID小鼠的肺内气管内滴注了正常的和IFN-γ活化的巨噬细胞。我们证明了巨噬细胞的气道递送导致广泛的肺泡分布,改善的吞噬功能和清除机会感染如卡氏肺孢子虫的能力。气道递送表达IFN-γ的巨噬细胞进一步增强了肺泡巨噬细胞的功能。尽管进行中的全身性免疫抑制,正常或激活的AM免疫重建的小鼠的肺重构可以恢复肺泡免疫。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号